Michael P. Pender
Herston, QLD, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Epstein-Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: (Trends in Molecular Medicine, 26:3 p:296-310, 2020).
Journal: Trends in molecular medicine
Published: February 20, 2021
Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein-Barr Virus-Specific T Cell Therapy.
Journal: Frontiers in neurology
Published: January 13, 2021
Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis.
Journal: JCI insight
Published: October 15, 2020
Correlations between macrophage/microglial activation marker sTREM-2 and measures of T-cell activation, neuroaxonal damage and disease severity in multiple sclerosis.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: October 09, 2020
Reduced IκB-α Protein Levels in Peripheral Blood Cells of Patients with Multiple Sclerosis-A Possible Cause of Constitutive NF-κB Activation.
Journal: Journal of clinical medicine
Published: July 09, 2020
Correlation Between Anti-Myelin Proteolipid Protein (PLP) Antibodies and Disease Severity in Multiple Sclerosis Patients With PLP Response-Permissive HLA Types.
Journal: Frontiers in immunology
Published: November 30, 2019
Epstein-Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies.
Journal: Trends in molecular medicine
Published: July 18, 2019
PLP1 Mutations in Patients with Multiple Sclerosis: Identification of a New Mutation and Potential Pathogenicity of the Mutations.
Journal: Journal of clinical medicine
Published: September 27, 2018
Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis.
Journal: JCI insight
Published: September 11, 2018
Increased constitutive activation of NF-κB p65 (RelA) in peripheral blood cells of patients with progressive multiple sclerosis.
Journal: Journal of neuroimmunology
Published: December 06, 2017
Erratum: Defective T-cell control of Epstein-Barr virus infection in multiple sclerosis.
Journal: Clinical & translational immunology
Published: July 28, 2017
Reactivity to Novel Autoantigens in Patients with Coexisting Central Nervous System Demyelinating Disease and Autoimmune Thyroid Disease.
Journal: Frontiers in immunology
Published: February 23, 2017
Last Updated: 09/26/2026